PTC Therapeutics Inc’s recent filing unveils that its SVP, CHIEF ACCOUNTING OFFICER Utter Christine Marie unloaded Company’s shares for reported $79049.0 on Jan 08 ’26. In the deal valued at $76.45 per share,1,034 shares were sold. As a result of this transaction, Utter Christine Marie now holds 72,693 shares worth roughly $5.64 million.
Then, Pauwels Eric sold 4,602 shares, generating $352,057 in total proceeds. Upon selling the shares at $76.50, the CHIEF BUSINESS OFFICER now owns 82,887 shares.
Before that, Pauwels Eric sold 1,722 shares. PTC Therapeutics Inc shares valued at $133,300 were divested by the CHIEF BUSINESS OFFICER at a price of $77.41 per share. As a result of the transaction, Pauwels Eric now holds 81,165 shares, worth roughly $6.3 million.
RBC Capital Mkts downgraded its PTC Therapeutics Inc [PTCT] rating to a Sector perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in mid October with a ‘”an Overweight”‘ rating. Truist began covering PTCT with “Buy” recommendation on June 17, 2025. BofA Securities revised its rating on May 09, 2025. It rated PTCT as “a Buy” which previously was an “a Neutral”.
Price Performance Review of PTCT
On Monday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock jump 0.08% to $77.59. Over the last five days, the stock has gained 1.08%. PTC Therapeutics Inc shares have risen nearly 72.27% since the year began. Nevertheless, the stocks have risen 2.15% over the past one year.
How much short interest is there in PTC Therapeutics Inc?
A steep rise in short interest was recorded in PTC Therapeutics Inc stocks on 2025-12-31, dropping by -2.15 million shares to a total of 10.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 12.86 million shares. There was a decline of -20.07%, which implies that there is a negative sentiment for the stock.
